Navigation Links
Iowa State researcher develops new treatment method for canine eye diseases
Date:10/28/2008

AMES, Iowa -- An Iowa State University researcher is exploring a new method of getting medicine to the eyes of infected dogs that is more effective and reliable than using eye drops.

Dr. Sinisa Grozdanic, an assistant professor of veterinary clinical sciences at Iowa State's College of Veterinary Medicine, is working with a drug manufacturer to develop a method of implanting biodegradable medicine into the tissue surrounding a dog's eyes. The medicine releases gradually and treats the infected eye for an entire year.

This is the first time the procedure has been tried to improve auto-immune corneal diseases that can cause pain, redness, inflammation and other eye problems for canines.

This type of drug application is designed to replace eye drops that may require an owner to put drops in a dog's eyes several times a day, sometimes without noticeable effect.

"With drops, immediately after putting them in the eye, there is a lot of medicine going where it needs to go," said Grozdanic. "Then the amount of medicine getting into the eye goes down quickly. Also, you have a specific time for how long that drug will be therapeutically active."

With drops, there are also other issues such as missing a dose and not getting all the medicine into a fidgety dog's eyes.

"It's a hassle for the owner to get the drops in. It is a hassle for the dog as well," he said.

By putting this small pellet inside the tissue surrounding the eye, medicine constantly gets to the needed area for an entire year, he said.

"With this new method, you don't miss a dose. And it works for 24 hours for an entire year."

The polymer is made by the company Nicast Ltd. in Israel, which is developing the technology for both animal and human use.

The technology the company uses is called electrospinning. In making the implant, the needed drug is mixed with a polymer and formed into ultra-fine fibers.
'/>"/>

Contact: Sinisa Grozdanic
sgrozdan@iastate.edu
515-294-4900
Iowa State University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Obesity and the central nervous system -- the state of the art
2. University of Minnesota study refutes belief that black men have more aggressive prostate cancer
3. Iowa State University conference examines developing bioeconomy
4. University and state agencies to forecast local health effects of climate change
5. K-State Veterinary Lab routinely tests for bluetongue virus
6. New prostate cancer research findings
7. Iowa State professors genome research published in the latest issue of Science
8. Leading researchers to reveal comprehensive dos and donts for prostate cancer
9. K-State chemistry professor to receive Masao Horiba award
10. K-State sociologists use Department of Energy grant
11. NIH grants $33 M in institutional development awards to 3 states

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Iowa State researcher develops new treatment method for canine eye diseases
Iowa State researcher develops new treatment method for canine eye diseases
(Date:11/30/2009)...ing your extended family over the holidays was slo...the December 2009 print issue of the Journal of L...s that you might be right. Here,s the good news: r...new treatments that help keep autoimmune diseases ...hat,s because researchers from the University of C...
(Date:11/26/2009)...red deer have been caught in the hunters, sights f... than decorative. They are lethal weapons that sta... The University of York, UK, has been intrigued by... century and has become fascinated by the mechanic...llaboration with Tomas Landete-Castillejos at the ...
(Date:11/26/2009)...coccus Aureus ) and other drug-resistant bacteria ...prototype devices have been developed to offer saf...s. , Two prototype devices have been developed: ...g. hands and feet) in hospitals and public spaces ...er to shoot bacteria-killing agents into infested ...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Walk for Parkinson 26apos 3Bs Disease Scheduled for Saturday September 19 2009 53615 1Walk for Parkinson 26apos 3Bs Disease Scheduled for Saturday September 19 2009 53615 2Walk for Parkinson 26apos 3Bs Disease Scheduled for Saturday September 19 2009 53615 3Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level 13358 1Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level 13358 2Nile Therapeutics Inc Announces Dosing of First Patient in Phase 2 Study of CD NP for the Treatment of Acute Heart Failure 13356 1Nile Therapeutics Inc Announces Dosing of First Patient in Phase 2 Study of CD NP for the Treatment of Acute Heart Failure 13356 2Nile Therapeutics Inc Announces Dosing of First Patient in Phase 2 Study of CD NP for the Treatment of Acute Heart Failure 13356 3
...e may help people regain strength and normal use o... a University of California, Irvine study. , St...oved ability to grasp and release objects after th...tic Device (HOWARD). Each patient had at least mod...e right hand, although the affected hands were nei...
...a ?a form of cancer associated with asbestos expos... a combination of two cancer drugs, a large multic...essive form of cancer that occurs in the lining of...exposure to asbestos. There is no known cure. ,...isplatin ?along with the vitamin supplements folic...
...activity in the brain,s prefrontal cortex as subje...ions, researchers have been able to distinguish co...bjects, different plans. The findings, reported by... the Max Planck Institute for Human Cognitive and ...ent Biology online on February 8th. , Past researc...
Other Biology News:Robotic therapy helps restore hand use after stroke 2Robotic therapy helps restore hand use after stroke 3Chemo combination improves survival in asbestos-related cancer 2Chemo combination improves survival in asbestos-related cancer 3Reading hidden intentions in the human brain 2
(Date:11/30/2009)... , NOVATO, Calif., Nov. 30 /PRNewswire-FirstC...N ) announced today that the Food and Drug Adminis...for 3,4-diaminopyridine (3,4-DAP), amifampridine p...Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has pre...U. Also, in October 2009, the Committee for Medic...
(Date:11/30/2009)... , BOSTON and COPENHAGEN, Nov. 30 /PRNewsw...announced today that the Harvard Medical School IC...ecognized as a MicroRNA Screening Center of Excell...dical School, and associated hospitals and institu...cule and RNAi libraries. ,, MicroRNAs are a nov...
(Date:11/30/2009)... , AMSTERDAM, N... world,s,leading publisher of scientific, medical ...ed a major re-launch of Embase, its comprehensive ...dexed records from more than 7,000,active, peer re... a key role in the advancement of new biomedical,a...
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 /PRNewswire/ ... will initiate water-soluble carbon nanotube-based...The water-soluble carbon nanotubes, which have fun...ation with cancer drugs, was developed in partners... conjugated carbon nanotubes serves as a drug deli...
Breaking Biology Technology:FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
...hina, Jan. 14 /Xinhua-PRNewswire-FirstCall/ --,Chi...letin Board: CPHI),which develops, manufactures, a...oducts in China, today announced that it has retai...active and targeted investor,relations campaign. M...,collective team, will be advising the Company in ...
...he Institute for International,Research (IIR) has ...o lead,a workshop on actual case studies about way... using a Web-based integration of operations, achi...iciencies. The workshop will be,held 1:30 p.m. Wed...age,Congress in Scottsdale, Ariz. For registration...
...1 Barr Pharmaceuticals,Inc. (NYSE: BRL ) today c...c., has initiated a challenge of the patent listed...ts Namenda(R) (memantine,hydrochloride) tablets, 5... Application (ANDA) containing a,paragraph IV cert....S. Food,& Drug Administration (FDA) on October 16...
Other Biology Technology:China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 2China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program 3MedicareCRM(TM) to Speak at IIR Medicare Advantage Congress 2Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg 2Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg 3
...ease III digests duplex DNA in a 3'-> 5' direction...stretches of single-stranded DNA. Under defined re...III proceeds at a uniform rate yielding predictabl...onucleolytic excision of deoxyribonucleotides by E...
RNase H from Roche Applied Science
Goat Anti-Human Haptoglobin Polyclonal Antibody, Unconjugated from Abcam
Rat Anti-STENOTROPHOMONAS MALTOPHILIA Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: